Agios Pharmaceuticals (AGIO) FCF Margin Growth (5y) (2017 - 2025)
Analysis
Agios Pharmaceuticals (AGIO) FCF Margin Growth (5y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Agios Pharmaceuticals | 1.98 Bn | 1.98 Bn | 41.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -37,404.00 |
| Sep 30, 2025 | -48,495.00 |
| Jun 30, 2025 | -43,696.00 |
| Mar 31, 2025 | -115,923.00 |
| Dec 31, 2024 | -96,709.00 |
| Sep 30, 2024 | -60,747.00 |
| Jun 30, 2024 | -50,339.00 |
| Mar 31, 2024 | -87,285.00 |
| Dec 31, 2023 | -77,313.00 |
| Sep 30, 2023 | -39,740.00 |
| Jun 30, 2023 | -82,428.00 |
| Mar 31, 2023 | -55,786.00 |
| Dec 31, 2022 | -76,485.00 |
| Sep 30, 2022 | -132,888.00 |
| Jun 30, 2022 | -83,478.00 |
| Mar 31, 2022 | -1.14 Mn |
| Dec 31, 2020 | 31,703.00 |
| Sep 30, 2020 | 30,151.00 |
| Jun 30, 2020 | -15,829.00 |
| Mar 31, 2020 | -3,311.00 |